Terms: = Pancreatic cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
166 results:
1. IFNα-induced BST2
Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T
Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878
[TBL] [Abstract] [Full Text] [Related]
2. The EIF3H-HAX1 axis increases RAF-MEK-erk signaling activity to promote colorectal cancer progression.
Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
4. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.
Ren LK; Lu RS; Fei XB; Chen SJ; Liu P; Zhu CH; Wang X; Pan YZ
J Cancer Res Clin Oncol; 2024 Mar; 150(3):127. PubMed ID: 38483604
[TBL] [Abstract] [Full Text] [Related]
5. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of the RAF/MEK/erk Signaling Cascade in pancreatic cancer: Recent Advances and Future Perspectives.
Adamopoulos C; Cave DD; Papavassiliou AG
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
[TBL] [Abstract] [Full Text] [Related]
7. Dichotomous role of the serine/threonine kinase MAP4K4 in pancreatic ductal adenocarcinoma onset and metastasis through control of AKT and erk pathways.
Juin A; Spence HJ; Machesky LM
J Pathol; 2024 Apr; 262(4):454-466. PubMed ID: 38229581
[TBL] [Abstract] [Full Text] [Related]
8. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.
Beyer GV; Hueser S; Li R; Manika D; Lee M; Chan CHF; Howe JR; Ear PH
Surgery; 2024 Mar; 175(3):605-612. PubMed ID: 37914572
[TBL] [Abstract] [Full Text] [Related]
9. AKT and mTOR expression in human pancreatic ductal adenocarcinoma. Relevance for tumor biology.
Handra-Luca A
Pathol Res Pract; 2023 Nov; 251():154878. PubMed ID: 37890271
[TBL] [Abstract] [Full Text] [Related]
10. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
Sánchez-Tilló E; Pedrosa L; Vila I; Chen Y; Győrffy B; Sánchez-Moral L; Siles L; Lozano JJ; Esteve-Codina A; Darling DS; Cuatrecasas M; Castells A; Maurel J; Postigo A
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870961
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA UCA1 promotes pancreatic cancer cell migration by regulating mitochondrial dynamics via the MAPK pathway.
Wang H; Ding Y; He Y; Yu Z; Zhou Y; Gong A; Xu M
Arch Biochem Biophys; 2023 Oct; 748():109783. PubMed ID: 37816421
[TBL] [Abstract] [Full Text] [Related]
12. Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer.
Briseño-Díaz P; Schnoor M; Bello-Ramirez M; Correa-Basurto J; Rojo-Domínguez A; Arregui L; Vega L; Núñez-González E; Palau-Hernández LA; Parra-Torres CG; García Córdova OM; Zepeda-Castilla E; Torices-Escalante E; Domínguez-Camacho L; Xoconostle-Cazares B; Meraz-Ríos MA; Delfín-Azuara S; Carrión-Estrada DA; Villegas-Sepúlveda N; Hernández-Rivas R; Thompson-Bonilla MDR; Vargas M
Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37813486
[TBL] [Abstract] [Full Text] [Related]
13. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract] [Full Text] [Related]
14. GABRP Promotes the Metastasis of pancreatic cancer by Activation of the MEK/erk Signaling Pathway.
Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
[TBL] [Abstract] [Full Text] [Related]
15. Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/erk signaling axis.
Wu F; He J; Deng Q; Chen J; Peng M; Xiao J; Zeng Y; Yi L; Li Z; Tian R; Jiang Z
Biochem Biophys Res Commun; 2023 Jul; 664():108-116. PubMed ID: 37141638
[TBL] [Abstract] [Full Text] [Related]
16. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract] [Full Text] [Related]
17. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/erk phosphorylation.
Jiao J; Ruan L; Cheng CS; Wang F; Yang P; Chen Z
Mol Med; 2023 Apr; 29(1):47. PubMed ID: 37016317
[TBL] [Abstract] [Full Text] [Related]
18. Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis.
Shi T; Li X; Zheng J; Duan Z; Ooi YY; Gao Y; Wang Q; Yang J; Wang L; Yao L
Cell Oncol (Dordr); 2023 Aug; 46(4):969-985. PubMed ID: 37014552
[TBL] [Abstract] [Full Text] [Related]
19. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract] [Full Text] [Related]
20. PLA2G2A
Ge W; Yue M; Lin R; Zhou T; Xu H; Wang Y; Mao T; Li S; Wu X; Zhang X; Wang Y; Ma J; Wang Y; Xue S; Shentu D; Cui J; Wang L
Cancer Lett; 2023 Apr; 558():216095. PubMed ID: 36796670
[TBL] [Abstract] [Full Text] [Related]
[Next]
